ArticleAntiviral research2017

Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency.

Ludmila Perelygina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.